Marnix L Bosch

Title: Marnix L Bosch: Innovator in Glycoprotein Research

Introduction

Marnix L Bosch is a notable inventor based in Bellevue, WA (US). He has made significant contributions to the field of virology, particularly in the study of glycoproteins associated with herpes viruses. With a total of 4 patents to his name, Bosch's work has implications for diagnosing infections and developing immune responses.

Latest Patents

One of Bosch's latest patents focuses on Glycoprotein B of the RFHV/KSHV subfamily of herpes viruses. This invention involves polynucleotides encoding Glycoprotein B, derived from DNA extracts obtained from Macaque nemestrina and Macaque mulatta monkeys, as well as human AIDS patients affected by Kaposi's sarcoma. The research highlights the nucleotide sequences of a 319 base pair fragment, which shows a 76% identity between RFHV1 and KSHV. Additionally, the protein sequences encoded within these fragments exhibit a 91% identity between RFHV1 and KSHV. The full-length KSHV Glycoprotein B sequence includes a transmembrane domain and several potentially antigenic sites in the extracellular domain. This invention provides materials and methods to characterize Glycoprotein B encoding regions, which can be utilized for diagnosing infections and eliciting immune responses.

Career Highlights

Throughout his career, Marnix L Bosch has worked with esteemed institutions, including the University of Washington. His research has contributed to a deeper understanding of gamma herpes viruses and their associated glycoproteins.

Collaborations

Bosch has collaborated with notable colleagues such as Timothy M Rose and Kurt Strand, enhancing the impact of his research through teamwork and shared expertise.

Conclusion

Marnix L Bosch's innovative work in glycoprotein research has paved the way for advancements in the diagnosis and treatment of herpes virus infections. His contributions continue to influence the field of virology and immunology.